We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BIO.B market cap is 9.47B. The company's latest EPS is USD -22.3478 and P/E is -14.86.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 680.8M | 730.29M | 676.84M | 681.11M | 632.12M |
Operating Income | 98M | 114.08M | 61.91M | 89.62M | 90.95M |
Net Income | -164.23M | 833.49M | 68.96M | -1.16B | -476.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.31B | 2.55B | 2.92B | 2.8B | 2.67B |
Operating Income | 229.66M | 410.96M | 489.43M | 475.12M | 337.8M |
Net Income | 1.76B | 3.81B | 4.25B | -3.63B | -637.32M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.06B | 13.5B | 13.67B | 11.98B | 11.9B |
Total Liabilities | 3.6B | 3.89B | 3.9B | 3.53B | 3.48B |
Total Equity | 8.45B | 9.62B | 9.76B | 8.45B | 8.42B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 8.01B | 12.97B | 17.78B | 13.5B | 12.3B |
Total Liabilities | 2.25B | 3.09B | 4.11B | 3.89B | 3.56B |
Total Equity | 5.76B | 9.88B | 13.67B | 9.62B | 8.74B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 104.03M | 194.45M | 98.12M | 196.19M | 293.9M |
Investing | -1.14B | -1.21B | -70.47M | -42.49M | -51.99M |
Financing | 1.06B | 973.58M | 4.31M | -198.43M | -225.03M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 457.9M | 575.33M | 656.52M | 194.45M | 374.94M |
Investing | -208.89M | -60.25M | -784.44M | -1.21B | 20.21M |
Financing | -22.76M | -523.04M | -55.43M | 973.58M | -425.65M |
Market Cap | 9.47B |
Price to Earnings Ratio | -14.86 |
Price to Sales Ratio | 3.55 |
Price to Cash Ratio | 23.46 |
Price to Book Ratio | 1.08 |
Dividend Yield | - |
Shares Outstanding | 28.52M |
Average Volume (1 week) | 17 |
Average Volume (1 Month) | 183 |
52 Week Change | -28.42% |
52 Week High | 482.25 |
52 Week Low | 271.00 |
Spread (Intraday) | 66.46 (18.19%) |
Company Name | Bio Rad Laboratories Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.bio-rad.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions